...
首页> 外文期刊>Metabolic brain disease >Iron-dextran injection into the substantia nigra in rats decreases striatal dopamine content ipsilateral to the injury site and impairs motor function.
【24h】

Iron-dextran injection into the substantia nigra in rats decreases striatal dopamine content ipsilateral to the injury site and impairs motor function.

机译:在大鼠黑质中注射右旋糖酐铁可降低损伤部位同侧的纹状体多巴胺含量,并损害运动功能。

获取原文
获取原文并翻译 | 示例
           

摘要

Iron chloride injections into the rat SNc can cause chronic decreases in striatal dopamine (DA) levels. However, changes in striatal DA content after iron-dextran injection into rat SNc have not been completely elucidated. The aim of this work was to measure striatal DA concentrations after iron-dextran injection into the SNc. We divided 40 male Wistar rats into five groups, including control, saline injected then sacrificed 7 days or 30 days later, and iron-dextran injected then sacrificed 7 days or 30 days later. Striatal DA content was measured in control animals and in all animals sacrificed 7 days or 30 days after injection, and motor performance was assessed in iron-dextran and saline injected groups 30 days after injection. The striatal DA levels were determined using HPLC. There were significant (P < 0.05) decreases in DA concentrations in the striatum ipsilateral to the injection site in the iron-dextran treated rats compared to control and saline-injected rats. There were no significant differences in DA concentration between the sham-operated (i.e., saline-injected) and control rats. We also observed motor deficits in the iron-dextran injected rats. The striatal DA reduction observed after iron-dextran injection may be attributable to iron-induced oxidative injury in the SNc. Motor deficits, in turn, may be explained by subsequent disturbances in striatal and cortical dopaminergic neuromodulation.
机译:向大鼠SNc中注射氯化铁会导致纹状体多巴胺(DA)含量长期下降。然而,尚未完全阐明将铁右旋糖酐注射入大鼠SNc后纹状体DA含量的变化。这项工作的目的是测量右旋糖酐铁注入SNc后的纹状体DA浓度。我们将40只雄性Wistar大鼠分为5组,包括对照组,注射生理盐水然后在7天或30天后处死,以及注射右旋糖酐铁然后在7天或30天后处死。在对照动物和注射后7天或30天处死的所有动物中测量纹状体DA含量,并在注射后30天在右旋糖酐铁和盐水注射组中评估运动能力。使用HPLC测定纹状体DA水平。与对照组和盐水注射大鼠相比,铁-右旋糖酐治疗大鼠注射部位同侧纹状体中DA浓度显着降低(P <0.05)。在假手术(即注射盐水)和对照大鼠之间DA浓度没有显着差异。我们还观察到铁右旋糖酐注射大鼠的运动功能障碍。右旋糖酐注射后观察到的纹状体DA减少可能归因于SNc中铁诱导的氧化损伤。反过来,运动障碍可通过纹状体和皮质多巴胺能神经调节的后续障碍来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号